CB
BCRX icon

Commerce Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History

Commerce Bank’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Hold
38,310
– – ﹤0.01% 1063
2026
Q1 		$365K Sell
38,310
-755
-2% -$5.86K ﹤0.01% 1054
2025
Q4 		$305K Buy
39,065
+9,350
+31% +$67.6K ﹤0.01% 1076
2025
Q3 		$226K Sell
29,715
-1,625
-5% -$13.5K ﹤0.01% 1162
2025
Q2 		$281K Hold
31,340
– – ﹤0.01% 1054
2025
Q1 		$235K Buy
31,340
+290
+0.9% +$2.34K ﹤0.01% 1090
2024
Q4 		$233K Sell
31,050
-225
-0.7% -$1.71K ﹤0.01% 1104
2024
Q3 		$238K Sell
31,275
-1,035
-3% -$7.87K ﹤0.01% 1127
2024
Q2 		$200K Hold
32,310
– – ﹤0.01% 1154
2024
Q1 		$164K Buy
32,310
+13,645
+73% +$76.7K ﹤0.01% 1156
2023
Q4 		$112K Sell
18,665
-895
-5% -$5.19K ﹤0.01% 1157
2023
Q3 		$138K Sell
19,560
-555
-3% -$3.99K ﹤0.01% 1107
2023
Q2 		$142K Sell
20,115
-250
-1% -$2.01K ﹤0.01% 1115
2023
Q1 		$170K Buy
20,365
+5,760
+39% +$55.5K ﹤0.01% 1117
2022
Q4 		$168K Buy
14,605
+4,235
+41% +$52.8K ﹤0.01% 1087
2022
Q3 		$130K Buy
+10,370
New +$133K ﹤0.01% 1106
2022
Q2 		– Sell
-20,000
Closed -$325K – 1149
2022
Q1 		$325K Hold
20,000
– – ﹤0.01% 972
2021
Q4 		$277K Buy
20,000
+5,000
+33% +$66.2K ﹤0.01% 1038
2021
Q3 		$216K Buy
+15,000
New +$237K ﹤0.01% 1103

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Commerce Bank's BCRX Position: Q2 2026 in Review

Commerce Bank held its BioCryst Pharmaceuticals (BCRX) position steady in Q2 2026 at 38,310 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

Commerce Bank first reported a position in BCRX in Q3 2021 and has held it in 19 quarters since. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Commerce Bank held 38,310 shares of BioCryst Pharmaceuticals worth $383K as of Q2 2026.
  • Commerce Bank left its BioCryst Pharmaceuticals share count unchanged in Q2 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1063 holding.
  • Commerce Bank first reported a position in BioCryst Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.